380 related articles for article (PubMed ID: 24635537)
1. Transfection mechanisms of polyplexes, lipoplexes, and stealth liposomes in α₅β₁ integrin bearing DLD-1 colorectal cancer cells.
Adil MM; Erdman ZS; Kokkoli E
Langmuir; 2014 Apr; 30(13):3802-10. PubMed ID: 24635537
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol-dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO living cells.
Cardarelli F; Pozzi D; Bifone A; Marchini C; Caracciolo G
Mol Pharm; 2012 Feb; 9(2):334-40. PubMed ID: 22196199
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes.
Jain S; Kumar S; Agrawal AK; Thanki K; Banerjee UC
Mol Pharm; 2013 Jun; 10(6):2416-25. PubMed ID: 23597269
[TBL] [Abstract][Full Text] [Related]
4. Endocytic Transport of Polyplex and Lipoplex siRNA Vectors in HeLa Cells.
Lazebnik M; Keswani RK; Pack DW
Pharm Res; 2016 Dec; 33(12):2999-3011. PubMed ID: 27585903
[TBL] [Abstract][Full Text] [Related]
5. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes.
Rejman J; Bragonzi A; Conese M
Mol Ther; 2005 Sep; 12(3):468-74. PubMed ID: 15963763
[TBL] [Abstract][Full Text] [Related]
6. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
7. In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids.
Gaucheron J; Boulanger C; Santaella C; Sbirrazzuoli N; Boussif O; Vierling P
Bioconjug Chem; 2001; 12(6):949-63. PubMed ID: 11716686
[TBL] [Abstract][Full Text] [Related]
8. Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons.
da Cruz MT; Simões S; de Lima MC
Exp Neurol; 2004 May; 187(1):65-75. PubMed ID: 15081589
[TBL] [Abstract][Full Text] [Related]
9. Lipopolyplexes as nanomedicines for therapeutic gene delivery.
García L; Urbiola K; Düzgüneş N; Tros de Ilarduya C
Methods Enzymol; 2012; 509():327-38. PubMed ID: 22568913
[TBL] [Abstract][Full Text] [Related]
10. PR_b functionalized stealth liposomes for targeted delivery to metastatic colon cancer.
Adil M; Belur L; Pearce TR; Levine RM; Tisdale AW; Sorenson BS; McIvor RS; Kokkoli E
Biomater Sci; 2013 Apr; 1(4):393-401. PubMed ID: 32481904
[TBL] [Abstract][Full Text] [Related]
11. Increasing cancer-specific gene expression by targeting overexpressed α5β1 integrin and upregulated transcriptional activity of NF-κB.
Adil MM; Levine RM; Kokkoli E
Mol Pharm; 2014 Mar; 11(3):849-58. PubMed ID: 24483950
[TBL] [Abstract][Full Text] [Related]
12. DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes.
Kim BK; Hwang GB; Seu YB; Choi JS; Jin KS; Doh KO
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):1996-2001. PubMed ID: 26112463
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).
Li Y; Bhindi R; Deng ZJ; Morton SW; Hammond PT; Khachigian LM
Int J Cardiol; 2013 Oct; 168(4):3659-64. PubMed ID: 23886527
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic understanding of gene delivery mediated by highly efficient multicomponent envelope-type nanoparticle systems.
Pozzi D; Marchini C; Cardarelli F; Rossetta A; Colapicchioni V; Amici A; Montani M; Motta S; Brocca P; Cantù L; Caracciolo G
Mol Pharm; 2013 Dec; 10(12):4654-65. PubMed ID: 24188138
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
16. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
Garg A; Tisdale AW; Haidari E; Kokkoli E
Int J Pharm; 2009 Jan; 366(1-2):201-10. PubMed ID: 18835580
[TBL] [Abstract][Full Text] [Related]
17. Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes.
Remaut K; Sanders NN; Fayazpour F; Demeester J; De Smedt SC
J Control Release; 2006 Oct; 115(3):335-43. PubMed ID: 17010468
[TBL] [Abstract][Full Text] [Related]
18. Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically.
Eliyahu H; Joseph A; Schillemans JP; Azzam T; Domb AJ; Barenholz Y
Biomaterials; 2007 May; 28(14):2339-49. PubMed ID: 17298842
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
20. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
Shroff K; Kokkoli E
Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
